Table 2 Correlation between the studied biomarkers and the characteristics of the HCC group
From: Study on molecular expression of long non-coding RNA Glypican3 in hepatocellular cancer patients
GPC3 | lncRNA AF085935 | ||||||
|---|---|---|---|---|---|---|---|
Low expression (n = 34) | High expression (n = 36) | p value | Low expression (n = 34) | High expression (n = 36) | p value | ||
Age | 57 ± 7 | 57.8 ± 6.5 | 0.6 | 58.8 ± 7.6 | 56 ± 5.7 | 0.1 | |
Gender | Male | 30 (88.2%) | 30 (83.3%) | 0.55 | 29 (85.3%) | 31 (86.1%) | 0.9 |
Female | 4 (11.8%) | 6 (16.7%) | 5 (14.7%) | 5 (13.9%) | |||
Child Score | A | 25 (73.5%) | 0 (0%) | < 0.001 | 25 (73.5%) | 0 (0%) | < 0.001 |
B | 9 (26.5%) | 3 (8%) | 6 (17.6%) | 3 (8.4%) | |||
C | 0 (0%) | 33 (92%) | 3 (8.9%) | 33 (91.6%) | |||
No. of FLs | 1 | 19 (55.9%) | 22 (61.1) | 0.015 | 21 (61.8%) | 20 (55.6) | 0.12 |
2 | 10 (29.4%) | 2 (5.6%) | 8 (23.5%) | 4 (11.1%) | |||
multiple | 5 (14.7%) | 12 (33.3%) | 5 (14.7%) | 12 (33.3%) | |||
AFP | < 20 | 20 (58.8%) | 15 (41.7%) | 0.15 | 15 (44.1%) | 20 (55.6%) | 0.33 |
> 20 | 14 (41.2%) | 21 (58.3%) | 19 (55.9%) | 16 (44.4%) | |||
Vascular invasion | Yes | 3 (8.8%) | 5 (13.9%) | 0.5 | 6 (17.6%) | 34 (94.4%) | 0.003 |
No | 31 (92.2%) | 31 (86.1%) | 28 (82.4%) | 2 (5.6%) | |||
Abdominal LNs | Yes | 2 (5.9%) | 6 (16.7%) | < 0.001 | 7 (20.6%) | 35 (97.2%) | 0.019 |
No | 32(94.1%) | 30(83.3%) | 27(79.4%) | 1(2.8%) | |||